Велика Британія - англійська - myHealthbox

janssen-cilag ltd - risperidone - tablets - 3 mg - other antipsychotic - it al is used to treat the following: schizophrenia, mania, aggression in people with alzheimer’s dementia, aggression in intellectually disabled children (at least 5 years of age) and adolescents with conduct disorder.

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - daratumumab -

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - daratumumab -

Австралія - англійська - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - ibrutinib -

Європейський Союз - англійська - EMA (European Medicines Agency)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccines - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older.the use of this vaccine should be in accordance with official recommendations.

Європейський Союз - англійська - EMA (European Medicines Agency)

janssen-cilag international nv - fentanyl hydrochloride - pain, postoperative - analgesics - management of acute moderate to severe post-operative pain for use in a hospital setting only

Європейський Союз - англійська - EMA (European Medicines Agency)

janssen-cilag international nv - becaplermin - wound healing; skin ulcer - preparations for treatment of wounds and ulcers - regranex is indicated, in association with other good wound care measures, to promote granulation and thereby the healing of full-thickness, neuropathic, chronic, diabetic ulcers less than or equal to 5 cm2.

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - risperidone - orodispersible tablet - 4mg

Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - risperidone - orodispersible tablet - 3mg

Європейський Союз - англійська - EMA (European Medicines Agency)

janssen-cilag international nv - paliperidone palmitate - schizophrenia - psycholeptics - trevicta, a 3 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly paliperidone palmitate injectable product.